NMPA registration for medical devices in China refers to the process by which manufacturers or their authorized representatives obtain official approval from the National Medical Products Administration (NMPA) to legally market and sell their medical devices in China. This registration is mandatory for all medical devices marketed in China, ensuring they meet safety, efficacy, and quality standards set by the NMPA.
Device Classification: Determine the classification of your medical device according to the NMPA regulations. Devices are classified into Classes I, II, and III based on their risk level, with higher classes requiring more extensive documentation and stricter requirements.
Local Agent or Representative: If you are a foreign manufacturer, appoint a local agent or authorized representative in China. This representative will communicate with the NMPA on your behalf and assist in regulatory matters.
Documentation Preparation: Prepare comprehensive documentation, including:
Clinical Trials (if applicable): For some Class II and III devices, clinical trials conducted in China may be required. Ensure these trials are conducted according to NMPA regulations.
Application Submission: Submit your application and all required documentation to the NMPA. Applications are typically submitted through the NMPA's online platform or through a designated submission channel.
Technical Review and Evaluation: The NMPA will review your application and documentation. This process includes:
Registration Certificate Issuance: If your application is approved, the NMPA will issue a registration certificate. This certificate allows you to legally market and sell your medical device in China.
Post-Market Surveillance: After obtaining registration, comply with post-market surveillance requirements, including adverse event reporting and periodic reporting to the NMPA.
Contact Us:
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn